Unconfigured Ad

Collapse

Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by laura, 05-09-2011, 04:42 AM
35 responses
107,623 views
0 reactions
Last Post laura
by laura
 
Started by sci_guy, 01-23-2008, 11:19 PM
236 responses
684,223 views
1 reaction
Last Post ECO
by ECO
 
Started by tonybert, 08-17-2012, 10:41 AM
4 responses
3,542 views
0 reactions
Last Post pmiguel
by pmiguel
 
Started by rexxi, 08-16-2012, 12:05 PM
2 responses
1,486 views
0 reactions
Last Post JackieBadger  
Started by adaptivegenome, 08-17-2012, 05:20 AM
3 responses
2,065 views
0 reactions
Last Post adaptivegenome  
Started by noms, 08-17-2012, 06:12 AM
1 response
1,630 views
0 reactions
Last Post noms
by noms
 
Started by chsfredrick, 08-17-2012, 10:39 AM
1 response
1,661 views
0 reactions
Last Post chsfredrick  
Started by milesgr, 08-17-2012, 07:24 AM
1 response
1,360 views
0 reactions
Last Post behavin
by behavin
 
Started by biouser, 08-17-2012, 05:47 AM
Started by me91, 08-13-2012, 10:53 AM
12 responses
4,500 views
0 reactions
Last Post biouser
by biouser
 
Started by shrujan, 08-17-2012, 02:50 AM
1 response
6,636 views
0 reactions
Last Post SES
by SES
 
Started by asleo, 03-18-2012, 04:42 PM
2 responses
2,100 views
0 reactions
Last Post wanguan2000  
No topics found.
  • Time
Clear All
Posted Photos 1 Photo
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    Yesterday, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 02:55 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Working...